ARK Invest bets big on Figma despite its 83% valuation plunge

Neueste Nachrichten

ARK Invest bets big on Figma despite its 83% valuation plunge

Pie chart showing cryptocurrency market capitalizations in 2016, with sections for Bitcoin, Ethereum, Litecoin, and other cryptocurrencies on a white background.
Christine Miller
Christine Miller
2 Min.

ARK Invest bets big on Figma despite its 83% valuation plunge

ARK Invest, led by Cathie Wood, made only three stock purchases last week. The firm focused on Figma, Arcturus Therapeutics, and 10x Genomics while cutting back on several other holdings. One notable move involved a large investment in Figma, despite the company's recent valuation struggles.

On 20 March, ARK bought 337,381 shares of Figma, spending over $8.1 million. The privately held design software company has seen its valuation drop sharply—shares have fallen 83% from their 2025 peak, even though revenue grew by 40% in recent earnings. Unlike public stocks, Figma's share price isn't tracked in real time, with fluctuations tied to private funding rounds, market shifts, and past acquisition talks with Adobe.

Beyond Figma, ARK trimmed positions in multiple companies. The firm sold 45,998 shares of Circle Internet Group, a crypto-related holding, for around $5.9 million from its ARKK and ARKW funds. Other reduced stakes included Teradyne, Bullish, Guardant Health, and Butterfly Network. The limited buying activity marks a cautious approach by Wood's firm. Only three companies received fresh investments, signalling a selective strategy amid broader market adjustments.

ARK's latest trades highlight a focus on private tech while scaling back in other areas. The Figma purchase stands out due to its steep valuation decline, despite strong revenue growth. Meanwhile, the reduction in crypto and healthcare holdings reflects ongoing portfolio adjustments.